Showing 61 - 80 results of 1,827 for search '(( 3 1 decrease ) OR ( 10 ((peter decrease) OR (((nn decrease) OR (a decrease)))) ))*', query time: 0.23s Refine Results
  1. 61

    Allergenicity of roasted peanuts treated with a non-human digestive protease by Yu, Jianmei

    Published 2015
    “…The in vitro IgE-binding capacity of treated peanut extracts was determined by a competitive inhibition ELISA using pooled plasma of 10 peanut allergic patients. …”
    Get full text
    Get full text
    Get full text
  2. 62

    Three dimensional evaluation of the skeletal and temporomandibular joint changes following stabilization splint therapy in patients with temporomandibular joint disorders and mandi... by Ahmed, Madiha Mohammed Saleh

    Published 2023
    “…The mandibular rotation was significantly decreased from 3.58 ± 2.02° to 3.17 ± 1.60. The deviated side’s superior and posterior joint TMJ spaces were significantly increased from 2.49 ± 0.88 mm and 1.25 ± 0.79 mm to 2.98 ± 1.02 mm and 1.86 ± 0.72 mm, respectively. …”
    Get full text
    Get full text
    Get full text
  3. 63
  4. 64
  5. 65

    Bite force changes after surgical correction of mandibular prognathism in subjects with increased vertical dimension: A prospective clinical trial by Tamimi, Zaid Z.

    Published 2021
    “…Significant increase in MIOBF was observed at T1 (P < 0.001) followed by an insignificant decrease during the observation period (3–6 months after treatment; P > 0.05). …”
    Get full text
    Get full text
    Get full text
  6. 66
  7. 67
  8. 68

    Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes by Jung, Sungwook

    Published 2023
    “…Treatment of hyperglycemic NOD mice with MECA79-anti-CD3-NPs results in significant reversal of T1D compared to those that are untreated, treated with empty NPs, or provided free anti-CD3. …”
    Get full text
    Get full text
  9. 69
  10. 70

    The Expression of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscles of Insulin-Resistant Mice in Response to Sulforaphane by Rizk, Nasser M

    Published 2020
    “…Sulforaphane (SFN) has been suggested as a new potential anti-diabetic compound acting by reducing blood glucose levels through mechanisms not fully understood (1). …”
    Get full text
    Get full text
  11. 71
  12. 72
  13. 73
  14. 74

    Visible Light Photocatalytic Activity of Ag/WO3 Nanoparticles and its Antibacterial Activity Under Ambient Light and in The Dark by Maha, Matalkeh

    Published 2022
    “…Ultraviolet–visible spectra analysis observed a large redshift in the absorbing band edge and decreased bandgap energy from 2.6 to 2.1 eV. Photocatalytic analysis at different concentrations of 1% Ag/WO3 under visible light indicated a high degradation efficiency. …”
    Get full text
    Get full text
    Get full text
  15. 75

    Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants by Bin, Zhou

    Published 2017
    “…FindingsWe pooled 1479 studies that had measured the blood pressures of 19·1 million adults. Global age-standardised mean systolic blood pressure in 2015 was 127·0 mm Hg (95% credible interval 125·7–128·3) in men and 122·3 mm Hg (121·0–123·6) in women; age-standardised mean diastolic blood pressure was 78·7 mm Hg (77·9–79·5) for men and 76·7 mm Hg (75·9–77·6) for women. …”
    Get full text
    Get full text
    Get full text
  16. 76

    Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants by Bin, Zhou

    Published 2017
    “…FindingsWe pooled 1479 studies that had measured the blood pressures of 19·1 million adults. Global age-standardised mean systolic blood pressure in 2015 was 127·0 mm Hg (95% credible interval 125·7–128·3) in men and 122·3 mm Hg (121·0–123·6) in women; age-standardised mean diastolic blood pressure was 78·7 mm Hg (77·9–79·5) for men and 76·7 mm Hg (75·9–77·6) for women. …”
    Get full text
    Get full text
    Get full text
    article
  17. 77
  18. 78

    Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model by Al-Awar A.

    Published 2018
    “…Sitg oral treatment of different doses (25, 50, 100, and 150 mg/kg/day), or saline as a Control. Hearts were then isolated and subjected to two different I/R injury protocols: 10 min perfusion, 45 min regional ischemia, and 120 min reperfusion for infarct size (IS) measurement, or: 10 min perfusion, 45 min regional ischemia and 10 min reperfusion for biochemical analysis: nitric oxide synthases (NOSs) and DPP-4 activity, glucagon-like peptide-1 (GLP-1), Calcium, transient receptor potential vanilloid (TRPV)-1 and calcitonin gene-related peptide (CGRP) levels, transient receptor potential canonical (TRPC)-1 and e-NOS protein expression. …”
    Get full text
    Get full text
  19. 79
  20. 80